1. Home
  2. ACOG vs ACU Comparison

ACOG vs ACU Comparison

Compare ACOG & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • ACU
  • Stock Information
  • Founded
  • ACOG 2000
  • ACU 1867
  • Country
  • ACOG Canada
  • ACU United States
  • Employees
  • ACOG N/A
  • ACU N/A
  • Industry
  • ACOG
  • ACU Industrial Machinery/Components
  • Sector
  • ACOG
  • ACU Consumer Discretionary
  • Exchange
  • ACOG Nasdaq
  • ACU Nasdaq
  • Market Cap
  • ACOG 129.6M
  • ACU 145.9M
  • IPO Year
  • ACOG N/A
  • ACU N/A
  • Fundamental
  • Price
  • ACOG $7.72
  • ACU N/A
  • Analyst Decision
  • ACOG Strong Buy
  • ACU
  • Analyst Count
  • ACOG 1
  • ACU 0
  • Target Price
  • ACOG $20.00
  • ACU N/A
  • AVG Volume (30 Days)
  • ACOG 91.8K
  • ACU 13.1K
  • Earning Date
  • ACOG 11-14-2025
  • ACU 10-24-2025
  • Dividend Yield
  • ACOG N/A
  • ACU 1.61%
  • EPS Growth
  • ACOG N/A
  • ACU N/A
  • EPS
  • ACOG N/A
  • ACU 2.55
  • Revenue
  • ACOG $4,586,341.00
  • ACU $194,061,991.00
  • Revenue This Year
  • ACOG N/A
  • ACU $2.85
  • Revenue Next Year
  • ACOG $149.89
  • ACU $4.16
  • P/E Ratio
  • ACOG N/A
  • ACU $15.56
  • Revenue Growth
  • ACOG N/A
  • ACU 0.70
  • 52 Week Low
  • ACOG $3.75
  • ACU $34.35
  • 52 Week High
  • ACOG $11.54
  • ACU $45.42
  • Technical
  • Relative Strength Index (RSI)
  • ACOG 44.48
  • ACU N/A
  • Support Level
  • ACOG $7.27
  • ACU N/A
  • Resistance Level
  • ACOG $7.62
  • ACU N/A
  • Average True Range (ATR)
  • ACOG 0.59
  • ACU 0.00
  • MACD
  • ACOG 0.00
  • ACU 0.00
  • Stochastic Oscillator
  • ACOG 46.99
  • ACU 0.00

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

Share on Social Networks: